NOD1 and NOD2 of the innate immune system is differently expressed in human clear cell renal cell carcinoma, corresponding healthy renal tissue, its vasculature and primary isolated renal tubular epithelial cells

[1]  J. Kucharczyk,et al.  Targeting Toll-Like Receptors for Cancer Therapy , 2018, Targeted Oncology.

[2]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[3]  M. Dimopoulos,et al.  Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation. , 2017, The oncologist.

[4]  N. Warner,et al.  NOD1 and NOD2: signaling, host defense, and inflammatory disease. , 2014, Immunity.

[5]  M. Parlato,et al.  NOD-Like Receptors in Intestinal Homeostasis and Epithelial Tissue Repair , 2014, International journal of molecular sciences.

[6]  C. Fiocchi,et al.  Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis. , 2013, Gastroenterology.

[7]  S. Girardin,et al.  Phenotyping of Nod1/2 double deficient mice and characterization of Nod1/2 in systemic inflammation and associated renal disease , 2012, Biology Open.

[8]  Jong-Hwan Park,et al.  Activation of Nod1 and Nod2 induces innate immune responses of prostate epithelial cells , 2012, The Prostate.

[9]  A. King,et al.  Nod1 and Nod2 Are Expressed in Human and Murine Renal Tubular Epithelial Cells and Participate in Renal Ischemia Reperfusion Injury , 2010, The Journal of Immunology.

[10]  S. Schöniger,et al.  Immunohistochemical detection of NOD1 and NOD2 in the healthy murine and canine eye. , 2009, Veterinary ophthalmology.

[11]  M. Tomita,et al.  Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs , 2009, Proceedings of the National Academy of Sciences.

[12]  Lloyd J. Old,et al.  Adaptive immunity maintains occult cancer in an equilibrium state , 2007, Nature.

[13]  G. Núñez,et al.  Nod1/RICK and TLR Signaling Regulate Chemokine and Antimicrobial Innate Immune Responses in Mesothelial Cells1 , 2007, The Journal of Immunology.

[14]  K. Fukase,et al.  Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. , 2007, Molecular immunology.

[15]  J. Rosenbaum,et al.  Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. , 2006, Microvascular research.

[16]  Jiahuai Han,et al.  Nod1-dependent control of tumor growth. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Jun,et al.  Induction and localization of NOD2 protein in human endothelial cells. , 2005, Cellular immunology.

[18]  N. Rioux-Leclercq,et al.  Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience , 2005 .

[19]  B. Rini.  VEGF-targeted therapy in metastatic renal cell carcinoma. , 2005, The oncologist.

[20]  N. Suttorp,et al.  Nod1-Mediated Endothelial Cell Activation by Chlamydophila pneumoniae , 2005, Circulation research.

[21]  Judy H. Cho,et al.  Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis , 2003, Gut.

[22]  D. Podolsky,et al.  CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. , 2003, Gastroenterology.

[23]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[24]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[25]  Y. Ogura,et al.  Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides* , 2001, The Journal of Biological Chemistry.

[26]  L. del Peso,et al.  Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB* , 1999, The Journal of Biological Chemistry.

[27]  J. Bertin,et al.  Human CARD4 Protein Is a Novel CED-4/Apaf-1 Cell Death Family Member That Activates NF-κB* , 1999, The Journal of Biological Chemistry.

[28]  P. Baer,et al.  Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Technical note. , 1997, Kidney international.

[29]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[30]  W. Thoenes,et al.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. , 1986, Pathology, research and practice.

[31]  A. Gudkov,et al.  A In Vitro and In Vivo Study of the Ability of NOD1 Ligands to Activate the Transcriptional Factor NF-kB , 2011, Acta naturae.

[32]  J. Ting,et al.  CATERPILLER: a novel gene family important in immunity, cell death, and diseases. , 2005, Annual review of immunology.

[33]  S. Chen,et al.  Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. , 1999, The Journal of biological chemistry.